Anti-PD-1 antibody treatment for melanoma

被引：0
|
作者：
Ribas, Antoni [1 ,2 ]
Kirkwood, John M. [3 ]
Flaherty, Keith T. [4 ]
机构：
[1] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Los Angeles, CA 90095 USA
[2] Parker Inst, Canc Immunotherapy Ctr, San Francisco, CA 94129 USA
[3] Univ Pittsburgh, Hillman UPMC Canc Ctr, Melanoma & Skin Canc Program, Pittsburgh, PA USA
[4] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 05期
关键词：
PEMBROLIZUMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E219 / E219
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    [J]. LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
  • [2] Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
    Tumeh, Paul C.
    Hellmann, Matthew D.
    Hamid, Omid
    Tsai, Katy K.
    Loo, Kimberly L.
    Gubens, Matthew A.
    Rosenblum, Michael
    Harview, Christina L.
    Taube, Janis M.
    Handley, Nathan
    Khurana, Neharika
    Nosrati, Adi
    Krummel, Matthew F.
    Tucker, Andrew
    Sosa, Eduardo V.
    Sanchez, Phillip J.
    Banayan, Nooriel
    Osorio, Juan C.
    Nguyen-Kim, Dan L.
    Chang, Jeremy
    Shintaku, I. Peter
    Boasberg, Peter D.
    Taylor, Emma J.
    Munster, Pamela N.
    Algazi, Alain P.
    Chmielowski, Bartosz
    Dummer, Reinhard
    Grogan, Tristan R.
    Elashoff, David
    Hwang, Jimmy
    Goldinger, Simone M.
    Garon, Edward B.
    Pierce, Robert H.
    Daud, Adil
    [J]. CANCER IMMUNOLOGY RESEARCH, 2017, 5 (05) : 417 - 424
  • [3] A Case of Acute Myocarditis During Treatment With Anti-PD-1 Antibody Nivolumab in a Melanoma Patient
    Tadokoro, Tomonori
    Keshino, Eri
    Mohri, Masahiro
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S220 - S220
  • [4] Anti-PD-1 Therapy in Melanoma
    Moreno, Blanca Hornet
    Parisi, Giulia
    Robert, Lidia
    Ribas, Anton
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 466 - 473
  • [5] Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma
    Hersey, Peter
    Gowrishankar, Kavitha
    [J]. FUTURE ONCOLOGY, 2015, 11 (01) : 133 - 140
  • [6] Thiazolidinedione enhances the efficacy of anti-PD-1 monoclonal antibody in murine melanoma
    Zhang, Xinyi
    Gao, Yuan
    Tang, Keyun
    Li, Zongyu
    Halberstam, Alexandra A.
    Zhou, Liqun
    Perry, Rachel J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2024, 326 (03): : E341 - E350
  • [7] Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease
    Maul, Lara V.
    Weichenthal, Michael
    Kaehler, Katharina C.
    Hauschild, Axel
    [J]. JOURNAL OF IMMUNOTHERAPY, 2016, 39 (04) : 188 - 190
  • [8] Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update
    Gellrich, Frank Friedrich
    Schmitz, Marc
    Beissert, Stefan
    Meier, Friedegund
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [9] Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma
    Aya, Francisco
    Gaba, Lydia
    Victoria, Ivan
    Fernandez-Martinez, Aranzazu
    Tosca, Monica
    Prat, Aleix
    Arance, Ana
    [J]. FUTURE ONCOLOGY, 2016, 12 (23) : 2683 - 2688
  • [10] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Babacan, Nalan Akgul
    Eroglu, Zeynep
    [J]. CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
12345